Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
posted on
Apr 12, 2021 01:21PM
I think the key phrase there is "IF we see the positive results in Phase II". Should those positive results materialize in a significant and demonstrable way then that would be a game changer. If not then it could set things back for BoM2 more than if this Covid trial had not taken place at all. So, it's a risk but one they have to take.